5.12 USD
↘ 0.33 (5.98%)PRE MARKET (AS OF 04:10 AM EDT)
Unicycive Therapeutics, Inc. Common Stock
UNCYNASDAQ • USD
Market: OPEN
UNCY is currently priced at $5.12. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. UNCY is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Jul 21, 2026.
Open?$5.59
High?$5.72
Low?$5.59
Prev. Close?$5.45
Volume?1.6K
Avg. Volume?2.3M
VWAP?$5.67
Rel. Volume?0.00x
Bid / Ask
Bid?$4.65 × 100
Ask?$6.67 × 100
Spread?$2.02
Midpoint?$5.66
Valuation & Ratios
Market Cap?155.9M
Shares Out?27.4M
Float?26.1M
Float %?97.8%
P/E Ratio?N/A
P/B Ratio?4.13
EPS?-$1.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
Employees
22
Market Cap
149.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-07-13
Address
1975 W. EL CAMINO REAL, SUITE 204
MOUNTAIN VIEW, CA 94040
Phone: 650-384-0642
MOUNTAIN VIEW, CA 94040
Phone: 650-384-0642
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?1
Momentum?50
Short Sent.?54
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.40Distress
Confidence?50%Low
Short InterestHigh
Short % of Float?17.90%High
Short Interest?4.7M
Days to Cover?1.2
Free Float26.1M
Avg Daily Volume3.9M
Settlement Date2026-06-30
Financial Health
Current Ratio?2.40Strong
Quick Ratio?2.40Strong
Cash Ratio?1.41Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.13FAIR▾
Peers100
S&P43
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.0CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-106.0%WEAK▾
S&P3
ROA?-62.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-28671000
Enterprise Value?$118.5M
Fundamentals ratios updated end of day